Skip to content

Comparison of Prefilled syringe and Autoinjector presentations of FYB202

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-522422-13-00
Acronym
FYB202-004
Enrollment
160
Registered
2025-11-03
Start date
2025-11-15
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic inflammatory diseases

Interventions

None listed

Sponsors

Fresenius Kabi SwissBioSim GmbH
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Poland

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026